Beta glucuronidase short-term immunotherapy prevents seasonal rhinoconjunctivitis in grass pollen allergic patients by modifying dendritic cell phenotype

被引：0
|
作者：
Di Stanislao, C
Angelini, F
Gagliardi, MC
Feccia, T
Di Berardino, L
Moschese, V
Chini, L
Polito, A
Riccardi, C
Rossi, P
机构：
[1] Dept Allergol, ASL 104, Laquila, Italy
[2] Tor Vergata Univ, Dept Pediat, Rome, Italy
[3] Childrens Hosp Bambino Gesu, Dept Pediat, Div Immunol & Infect Dis, Rome, Italy
来源：
ALLERGY | 2002年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：76 / 77
页数：2
相关论文
共 50 条
  • [1] Beta glucuronidase short-term immunotherapy
    Di Stanislao, C
    Angelini, F
    Gagliardi, MC
    Di Bernardino, L
    Fundaro', C
    Galli, E
    Rossi, P
    ALLERGY, 2003, 58 (05) : 459 - 459
  • [2] Effect of grass pollen immunotherapy with Alutard SQ® on quality of life in seasonal allergic rhinoconjunctivitis
    Powell, R. J.
    Frew, A. J.
    Corrigan, C. J.
    Durham, S. R.
    ALLERGY, 2007, 62 (11) : 1335 - 1338
  • [3] Ultrashort-specific immunotherapy successfully treats seasonal allergic rhinoconjunctivitis to grass pollen
    DuBuske, Lawrence H.
    Frew, Anthony J.
    Horak, Friedrich
    Keith, Paul K.
    Corrigan, Christopher J.
    Aberer, Werner
    Holdich, Tom
    von Weikersthal-Drachenberg, Karl J. Fischer
    ALLERGY AND ASTHMA PROCEEDINGS, 2011, 32 (03) : 239 - 247
  • [4] Short-term effects of airborne pollen on the risk of allergic rhinoconjunctivitis
    Zeghnoun, Abdelkrim
    Ravault, Coralie
    Fabres, Bruno
    Lecadet, Jerome
    Quenel, Philippe
    Thibaudon, Michel
    Caillaud, Denis
    ARCHIVES OF ENVIRONMENTAL & OCCUPATIONAL HEALTH, 2005, 60 (03) : 170 - 176
  • [5] SQ grass sublingual allergy immunotherapy tablet for disease-modifying treatment of grass pollen allergic rhinoconjunctivitis
    Dahl, Ronald
    Roberts, Graham
    de Blic, Jacques
    Canonica, G. Walter
    Kleine-Tebbe, Joerg
    Nolte, Hendrik
    Lawton, Simon
    Nelson, Harold S.
    ALLERGY AND ASTHMA PROCEEDINGS, 2016, 37 (02) : 92 - 104
  • [6] Study of impact of subcutaneous pre-seasonal tree and/or grass pollen immunotherapy (with MPL adjuvant) on patients with allergic rhinoconjunctivitis
    Azmi, S.
    Tsoumani, M.
    Liau, J. L.
    Addison, J.
    Burrows, H.
    Chew, F.
    Marinho, S.
    ALLERGY, 2019, 74 : 334 - 335
  • [7] From Evidence-Based Medicine to Practice in Specific Grass Pollen Immunotherapy of Seasonal Allergic Rhinoconjunctivitis
    Calderon, M.
    Moesges, R.
    Hellmich, M.
    Demoly, P.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : AB123 - AB123
  • [8] Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen
    Patel, Piyush
    Holdich, Tom
    von Weikersthal-Drachenberg, Karl J. Fischer
    Huber, Birgit
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (01) : 121 - +
  • [9] Quality of life benefits for patients with seasonal grass pollen-allergic rhinoconjunctivitis receiving ultra short course subcutaneous immunotherapy (uSCIT) with MPL adjuvant
    Keith, P.
    Amersdorffer, J.
    ALLERGY, 2009, 64 : 348 - 348
  • [10] Design of a phase III short-term efficacy study with allergen specific immunotherapy in patients with birch pollen induced allergic rhinitis/rhinoconjunctivitis
    van Nimwegen, M.
    Pfaar, O.
    Kuna, P.
    Panzner, P.
    Dzupinova, M.
    Boot, D.
    Bachert, C.
    ALLERGY, 2015, 70 : 454 - 454
12345